Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey

Lisa K. Stamp, William Taylor and Angelo Gaffo for the Gout and Crystal Arthritis Network
The Journal of Rheumatology January 2021, 48 (1) 152-153; DOI: https://doi.org/10.3899/jrheum.200347
Lisa K. Stamp
1University of Otago, Christchurch, New Zealand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa K. Stamp
  • For correspondence: Lisa.Stamp@cdhb.health.nz
William Taylor
2University of Otago, Wellington, New Zealand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William Taylor
Angelo Gaffo
3University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angelo Gaffo
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 48 no. 1 152-153
DOI 
https://doi.org/10.3899/jrheum.200347
PubMed 
33004535

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online January 1, 2021.

Article Versions

  • Latest version (October 1, 2020 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021

Author Information

  1. Lisa K. Stamp1, MBChB, FRACP, PhD⇑,
  2. William Taylor2, MBChB, MRChB, PhD, FRACP and
  3. Angelo Gaffo3, MD, MSPH; for the Gout and Crystal Arthritis Network
  1. 1University of Otago, Christchurch, New Zealand;
  2. 2University of Otago, Wellington, New Zealand;
  3. 3University of Alabama at Birmingham, Birmingham, Alabama, USA.
  1. Address correspondence to Prof. L. Stamp, Department of Medicine, University of Otago Christchurch, PO Box 4345, Christchurch 8140, New Zealand. Email: Lisa.Stamp{at}cdhb.health.nz.

Article usage

Article usage: September 2020 to February 2023

AbstractFullPdf
Sep 2020201
Oct 20202890139
Nov 202066021
Dec 202031218
Jan 202123295465
Feb 20215646229
Mar 20214446713
Apr 20214343318
May 2021698014
Jun 2021115210
Jul 2021164123
Aug 202115517
Sep 2021142517
Oct 202172123
Nov 20211011215
Dec 202161118
Jan 202210108
Feb 20228108
Mar 202255346
Apr 20229157
May 20224812
Jun 2022688
Jul 2022161
Aug 20226172
Sep 20226612
Oct 2022355
Nov 2022776
Dec 2022254
Jan 20234108
Feb 20238121

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 48, Issue 1
1 Jan 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey
Lisa K. Stamp, William Taylor, Angelo Gaffo
The Journal of Rheumatology Jan 2021, 48 (1) 152-153; DOI: 10.3899/jrheum.200347

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey
Lisa K. Stamp, William Taylor, Angelo Gaffo
The Journal of Rheumatology Jan 2021, 48 (1) 152-153; DOI: 10.3899/jrheum.200347
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion?
  • Drs. Ramdani and Audemard-Verger reply
  • Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire